Pharmaceuticals News and Research

RSS

New target for diagnosis and treatment of ovarian cancer

An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago.

10 Apr 2007

Barr Pharmaceuticals receives Notice of Allowance for Seasonale patent

Barr Pharmaceuticals has announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for the reissuance of U.S. Patent 5,895,032 ('032), relating to Barr's SEASONALE extended-cycle oral contraceptive.

10 Apr 2007

India is poised to revolutionize biotechnology

India's health biotech firms are emerging as a major global player, with growing means and know-how to produce innovative as well as generic drugs and vaccines at costs small relative to those of giant Western firms, according to ground-breaking Canadian research.

10 Apr 2007

Development of magnetic cationic liposomes for targeting tumor microvasculature

A popular way to attack malignant tumors is using cationic liposomes as drug delivery systems.

10 Apr 2007

Epilepsy drug retigabine safe and effective

A drug for epilepsy with a new mechanism of action is safe and effective, according to a study published in the April 10, 2007, issue of Neurology", the scientific journal of the American Academy of Neurology.

10 Apr 2007

Atrium Medical receives FDA approval for Omega 3 surgical mesh product

Atrium Medical Corporation is pleased to announce it has obtained US FDA 510(K) approval for a new Omega 3 surgical mesh product called C-QURLite(TM) Mesh.

10 Apr 2007

Efficacy of Guanilib confirmed for inflammatory bowel disease

Callisto Pharmaceuticals has announced additional data confirming efficacy of Guanilib, a first-in-class compound currently being developed for the treatment of inflammatory bowel disease (IBD), in two different standard animal models of experimental colitis.

7 Apr 2007

Alteon expands agreement with Biorap Technologies

Alteon has announced that it has entered into an expanded licensing agreement with BioRap Technologies, the commercialization arm of the Rappaport Family Institute for Research, Technion University, Israel, for all diagnostic devices or products for predictive purposes in vascular or cardiac diseases, including diagnostic assays for the measurement of the haptoglobin protein (Hp).

7 Apr 2007

PhRMA statement on the Medicare prescription drug program

Pharmaceutical Research and Manufacturers of America Senior Vice President Ken Johnson issued the following statement on the AARP's campaign to modify the Medicare prescription drug program.

5 Apr 2007

Market study into the distribution of medicines in the UK

The OFT has launched a market study into the distribution of medicines in the UK. This decision follows recent and proposed distribution changes by leading UK medicine suppliers.

5 Apr 2007

Bayer Healthcare Pharmaceuticals launches in the U.S.

Bayer HealthCare Pharmaceuticals Inc. today announced its official U.S. launch. The new company incorporates the former Berlex Inc.into Bayer HealthCare Pharmaceuticals, as part of Bayer's acquisition of Schering AG, Germany, Berlex's former parent company.

5 Apr 2007

AARP asks U.S. Senator Coleman to stand up to big pharma

AARP State President Skip Humphrey stood with a group of red-shirted AARP members and representatives of the Minnesota Senior Federation and the Elder Care Rights Alliance to urge U.S. Senator Norm Coleman to support legislation to give Medicare the authority to negotiate with drug companies for lower prescription drug prices.

5 Apr 2007

Stanford technique directly controls brain cell activity with light

Every thought, feeling and action originates from the electrical signals emitted by diverse brain cells enmeshed in a tangle of circuits.

5 Apr 2007

NewYork-Presbyterian and AstraZeneca collaborate in series of cancer studies

NewYork-Presbyterian Hospital is one of six centers nationally to be selected for collaboration with AstraZeneca for an ongoing series of Phase II clinical trials of various novel compounds for potential treatment of a wide variety of cancers.

5 Apr 2007

CleveMed completes first virtually attended home sleep study using mobile phone broadband internet service

Cleveland Medical Devices Inc. (CleveMed) announced that it recently conducted the first virtually attended sleep study using mobile phone broadband internet service from a subject's home.

5 Apr 2007

No apparent increase in coronary heart disease for women who initiate hormone therapy

Wyeth Pharmaceuticals, a division of Wyeth ( NYSE:WYE ) , provides comment on a re- analysis of pooled data from both hormone therapy arms of the Women's Health Initiative (WHI) Study published today in the Journal of the American Medical Association.

4 Apr 2007

Sheep gene research sheds light on human condition - ectodermal dysplasia

Sheep gene research at the University of Adelaide's Roseworthy Campus aimed at helping maximise wool production for Australian producers, has shed light on a human genetic hair and skin disorder.

4 Apr 2007

Scientists take a close look at early events in immune response

A Sandia National Laboratories research team led by Anup Singh is taking a new approach to studying how immune cells respond to pathogens in the first few minutes and hours of exposure.

4 Apr 2007

Targeted therapies improve colon cancer survival rates

People diagnosed with advanced colorectal cancer that has spread to distant organs, such as White House spokesman Tony Snow, are much more likely to survive today than even just a few years ago, due to the recent and continued emergence of improved therapies, say cancer experts.

3 Apr 2007

Millions of children living with HIV/AIDS in developing countries need immediate access to treatment

There is an immediate need for the provision of antiretroviral therapy developed for children, including smaller pills and combination therapies, as well as enhanced medical training to provide care to HIV-positive children in developing countries, according to an American Academy of Pediatrics policy statement published on Monday in the April issue of the journal Pediatrics, the AP/San Francisco Chronicle reports.

3 Apr 2007